Heparin sodium is mainly used in hemodialysis or hemofiltration to prevent
blood clotting during cardiopulmonary bypass and to prevent thrombosis. The drug
is mainly used in hemodialysis for the prevention of clotting and deep vein
thrombosis, unstable angina, and for the prevention of surgically related
Needs to be individualized dosage, in terms of dosage of the drug in the application process may produce adverse reaction, can lead to bleeding, especially large dose application that may lead to subcutaneous hematoma, may also cause thrombocytopenia, skin necrosis, allergic reactions, rare is likely to trigger transaminase lifts.
The drug also has contraindications in the course of application. It should not be used in patients with acute gastroduodenal ulcer, cerebral hemorrhage, severe clotting disease, septic endocarditis. Patients with positive platelet aggregation test results for thrombocytopenia in patients with CNS eye and ear injuries or surgical use of heparin are prohibited. In the treatment of acute pulmonary thrombosis, the use of local anesthetic drugs must be cautious.